Relugolix Combination

N/A

Report date: 2024/09/23 17:46:30
NME

Base Information

Drug NameRelugolix Combination
Drug Alias NameAKP-022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone receptor antagonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsUterine DiseasesEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsYes
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAska Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAska Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsUterine DiseasesEndometriosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A